Subrata Debnath, MBBS, MPH, PhD
Neurobehavioral symptoms such as fatigue and depression are highly prevalent in patients with chronic kidney disease (CKD) especially in end-stage kidney disease. However, research elucidating the etiology of these symptoms is limited. My overall research focus is to examine the relationship of deranged essential amino acids and fatigue and depression in advanced CKD. I am also interested in evaluating the efficacy of nutritional interventions in mitigating these symptoms and other renal outcomes in patients with kidney disease.
- 2004 - Ph.D. - Dietetics and Nutrition - Robert Stempel College of Public Health and Social Work
- 1998 - MPH - Epidemiology - Robert Stempel College of Public Health and Social Work
- 1992 - MB.BS - Medicine - Sher-E-Bangla Medical College, University of Dhaka, Bangladesh
Research & Grants
Debnath, S (Co-PI; PI, Kumar Sharma) 2020 – 2022 $200,000
Funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
NIRVANA: NIcotinamide Riboside in SARS-CoV-2 pAtients for reNAl protection
The primary objective is to evaluate the effect of nicotinamide riboside on acute kidney injury in COVID-19 patients admitted to hospital.
- Debnath S, Lorenzo C, Bansal S, et al. Branched-chain amino acids depletion during hemodialysis is associated with fatigue. Am J Nephrol. 2020;51(7):565-571. doi: 10.1159/000507839
- Debnath S, Rueda R, Bansal S, Sharma K, Lorenzo C. Assessment of fatigue in hemodialysis patients: Performance of the brief fatigue inventory. General Hospital Psychiatry. 2020. doi.org/10.1016/j.genhosppsych.2020.08.006
- Debnath S, O'Connor J, Hura C, Kasinath B, Lorenzo C. Quality of Life and Depression Among Mexican Americans on Hemodialysis: A Preliminary Report. Ther Apher Dial. 2018;22(2):166-170. doi: 10.1111/1744-9987.12642. PMID: 29193825.